S
Shanghai Paralon Biotechnology
Parylene conformal coating services for multiple industries
About Shanghai Paralon Biotechnology
Shanghai Paralon Biotechnology Co., Ltd. is a high-tech enterprise specializing in the application of Parylene and other special coating technologies. Founded in December 2012, the company's core team has over two decades of experience in Parylene material research and application. The founder and CEO is Zhang Jingang. The legal representative is Zhang Yue, who also serves as the chairman.
The company focuses on providing Parylene coating services, which are protective polymer coatings applied through a chemical vapor deposition (CVD) process in a vacuum. This process ensures a uniform, pinhole-free, and thin protective layer that conforms to any shape. Paralon has developed its own production equipment and holds 22 national patents and 10 software copyrights. Their services cater to a wide range of industries, including medical devices, electronics, automotive, aerospace, military, and semiconductor manufacturing. Key clients have included well-known companies like Huawei, ZTE, Philips, and MicroPort.
Paralon's business model encompasses providing comprehensive solutions from technical introductions and sample production to batch processing, sales of coating equipment, and raw materials. The company has secured significant funding to support its growth, including an A-round of over 50 million RMB in February 2023 from investors such as CITIC Construction Investment Capital and Yida Capital. This was followed by a B-round of nearly 100 million RMB in February 2026, led by SDIC Chuanghe. These funds are allocated for purchasing technical equipment, expanding and upgrading production lines, and for continuous research and development.
The firm operates out of clean workshops rated at various levels, including 100,000, 10,000, and static 100-class, and has obtained ISO9001 quality management system certification. Paralon has also developed proprietary composite functional coating technologies to solve issues related to material adhesion and to add properties like antibacterial and wear resistance.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2026 | $14M | $55M | SDIC Unity Capital · Detong Capital · Addor Capital | ↗ |
| SERIES A✓Equity / VC | Jan 2023 | $7.6M | $30M | China Securities · Detong Capital · Addor Capital · Su Guofa | ↗ |
Growth signals
Latest recorded traffic for Shanghai Paralon Biotechnology is 5.8K monthly website visits, up 1557.1% over the last three months. Shanghai Paralon Biotechnology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Paralon Biotechnology in its local ecosystem
The Shanghai Paralon Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- CSChina Securities
Detong CapitalAddor Capital
- SGSu Guofa
SDIC Unity Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Paralon Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Paralon Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








